Medications

Could nonprofit drug companies cut sky-high prices?

(HealthDay)—Generic prescription drugs should be cheap, but prices for some have soared in the United States in recent years. Now a group of U.S. hospitals thinks it has a solution: a nonprofit drug maker.

Cardiology

Outcomes-based pricing doesn't cut costs of PCSK9 inhibitors

(HealthDay)—Outcomes-based pricing does not reduce the costs of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, according to a research letter published online April 3 in the Annals of Internal Medicine.

Medications

Drug makers engage in 'co-opetition' through drug middlemen

Prescription drug consumers confounded by the cost of their medications can get a peek behind the curtain thanks to new Washington University in St. Louis research into the complex "co-opetition"—cooperation and competition—among ...

Health

Spending more on health care? Here's why

(HealthDay)—Americans spent more on health care in 2016, even though their use of health care did not increase, and rising costs are the reason why, a new report shows.

page 10 from 22